Medications

Last summer, we reported on the FDA approval of Leqembi, a medication that slows down cognitive decline in patients with Mild Cognitive Impairment or early Alzheimer’s Disease. While the medication is now covered by Medicare, patients who want access still have to demonstrate a diagnosis of Alzheimer’s and still have…

There are many reasons to be concerned about the safety and abilities of older drivers in this day and age, reasons that have nothing to do with outdated stereotypes or ageist tropes. There are currently 48 million drivers ages 65 and older on US roads, which is nearly 70% more…

As you likely know, Medicare is a federal program that provides health insurance to older Americans. Most people think Medicare is incredibly complicated (and it is), but if you break it down into pieces, it’s easier to understand and plan for your needs. In our desire to help you better…

There’s no doubt that we have entered an era when important opportunities will exist to delay or diminish the symptoms of dementia. As we’ve been covering in agebuzz, there is now a new drug (Leqembi) available to delay impairment and decline in patients with mild cognitive impairment or the early…

Have you jumped on the weight-loss medication bandwagon yet? Have you wondered whether there’s finally a way for you to shed those extra pounds that have been plaguing you for decades and return to your svelte days of yesteryear? Although we’ve previously told you that a bit of extra weight…

If you or a loved one suffers from mild cognitive impairment or have been diagnosed with early Alzheimer’s Disease, you’ve likely followed the news over the last few months about a new treatment awaiting FDA approval. Well, that FDA approval has arrived: Leqembi, a medication that targets the amyloid plaques…